CelluJuve for Nasolabial Folds

Overseen By Serpil Kucuktepe, PhD

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Spiderwort Biotechnologies Inc.

Must not be taking: Anticoagulants, NSAIDs, Corticosteroids, others

Disqualifiers: Pregnancy, Bleeding disorders, Cancer, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 10

Duration: 4 weeks

What You Need to Know Before You Apply

What is the purpose of this trial?

Single-center, open-label proof of concept study assessing the safety and effectiveness of CelluJuve® for the treatment of moderate to severe NLFs

Who Is on the Research Team?

Charles M Cuerrier, PhD

Principal Investigator

Spiderwort Biotechnologies Inc.

Are You a Good Fit for This Trial?

Inclusion Criteria

I have moderate to severe wrinkles on both sides of my nose and mouth.

My skin in the treatment area is healthy and free of other conditions.

4. Able to follow study instructions and complete all required visits.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive injections of CelluJuve® into both NLFs at Baseline and touch-up treatments at Week 4 if necessary

4 weeks

2 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness every 3 months through Month 24 after their last treatment

24 months

8 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

• CelluJuve®

How Is the Trial Designed?

Group I: CelluJuve® Experimental Treatment 1 Intervention

CelluJuve® injected into left and right NLF

Who Is Running the Clinical Trial?

Spiderwort Biotechnologies Inc.

Lead Sponsor